Keywords
Last Name
Institution

JAMES E CROWE

TitleAssociate Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Radiology
DivisionRadiology
AddressOne Baylor Plaza
Houston TX 770300000
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Crowe JE. Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine Design. Cell Host Microbe. 2017 Aug 09; 22(2):193-206. PMID: 28799905.
      View in: PubMed
    2. Crowe JE. Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Potential for a Universal Influenza Vaccine. Cold Spring Harb Perspect Biol. 2017 Jun 29. PMID: 28663208.
      View in: PubMed
    3. Mire CE, Geisbert JB, Borisevich V, Fenton KA, Agans KN, Flyak AI, Deer DJ, Steinkellner H, Bohorov O, Bohorova N, Goodman C, Hiatt A, Kim DH, Pauly MH, Velasco J, Whaley KJ, Crowe JE, Zeitlin L, Geisbert TW. Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody. Sci Transl Med. 2017 Apr 05; 9(384). PMID: 28381540.
      View in: PubMed
    4. Hasan SS, Miller A, Sapparapu G, Fernandez E, Klose T, Long F, Fokine A, Porta JC, Jiang W, Diamond MS, Crowe JE, Kuhn RJ, Rossmann MG. A human antibody against Zika virus crosslinks the E protein to prevent infection. Nat Commun. 2017 Mar 16; 8:14722. PMID: 28300075.
      View in: PubMed
    5. Thomsen IP, Sapparapu G, James DB, Cassat JE, Nagarsheth M, Kose N, Putnam N, Boguslawski KM, Jones LS, Wood JB, Creech CB, Torres VJ, Crowe JE. Monoclonal antibodies against the Staphylococcus aureus bicomponent leukotoxin AB (LukAB) isolated following invasive human infection reveal diverse binding and modes of action. J Infect Dis. 2017 Feb 10. PMID: 28186295.
      View in: PubMed
    6. Miner JJ, Cook LE, Hong JP, Smith AM, Richner JM, Shimak RM, Young AR, Monte K, Poddar S, Crowe JE, Lenschow DJ, Diamond MS. Therapy with CTLA4-Ig and an antiviral monoclonal antibody controls chikungunya virus arthritis. Sci Transl Med. 2017 Feb 01; 9(375). PMID: 28148840.
      View in: PubMed
    7. Wen X, Mousa JJ, Bates JT, Lamb RA, Crowe JE, Jardetzky TS. Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus. Nat Microbiol. 2017 Jan 30; 2:16272. PMID: 28134915.
      View in: PubMed
    8. Mousa JJ, Kose N, Matta P, Gilchuk P, Crowe JE. A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein. Nat Microbiol. 2017 Jan 30; 2:16271. PMID: 28134924.
      View in: PubMed
    9. Nivarthi UK, Kose N, Sapparapu G, Widman D, Gallichotte E, Pfaff JM, Doranz BJ, Weiskopf D, Sette A, Durbin AP, Whitehead SS, Baric R, Crowe JE, de Silva AM. Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to DENV4 Infection and Vaccination. J Virol. 2016 Dec 28. PMID: 28031369.
      View in: PubMed
    10. Sapparapu G, Fernandez E, Kose N. Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice. Nature. 2016 Dec 15; 540(7633):443-447. PMID: 27819683.
      View in: PubMed
    11. Gilchuk I, Gilchuk P, Sapparapu G, Lampley R, Singh V, Kose N, Blum DL, Hughes LJ, Satheshkumar PS, Townsend MB, Kondas AV, Reed Z, Weiner Z, Olson VA, Hammarlund E, Raue HP, Slifka MK, Slaughter JC, Graham BS, Edwards KM, Eisenberg RJ, Cohen GH, Joyce S, Crowe JE. Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections. Cell. 2016 Oct 20; 167(3):684-694.e9. PMID: 27768891.
      View in: PubMed
    12. Mousa JJ, Sauer MF, Sevy AM, Finn JA, Bates JT, Alvarado G, King HG, Loerinc LB, Fong RH, Doranz BJ, Correia BE, Kalyuzhniy O, Wen X, Jardetzky TS, Schief WR, Ohi MD, Meiler J, Crowe JE. Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein. Proc Natl Acad Sci U S A. 2016 Nov 01; 113(44):E6849-E6858. PMID: 27791117.
      View in: PubMed
    13. Culotta PA, Crowe JE, Tran QA, Jones JY, Mehollin-Ray AR, Tran HB, Donaruma-Kwoh M, Dodge CT, Camp EA, Cruz AT. Performance of computed tomography of the head to evaluate for skull fractures in infants with suspected non-accidental trauma. Pediatr Radiol. 2016 Oct 15. PMID: 27744559.
      View in: PubMed
    14. Shanker S, Czakó R, Sapparapu G, Alvarado G, Viskovska M, Sankaran B, Atmar RL, Crowe JE, Estes MK, Prasad BV. Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody. Proc Natl Acad Sci U S A. 2016 Oct 4; 113(40):E5830-E5837. PMID: 27647885.
      View in: PubMed
    15. Crowe JE. Teaching a Clone to Walk, One Step at a Time. Cell. 2016 Sep 8; 166(6):1360-1. PMID: 27610559.
      View in: PubMed
    16. Wec AZ, Nyakatura EK, Herbert AS, Howell KA, Holtsberg FW, Bakken RR, Mittler E, Christin JR, Shulenin S, Jangra RK, Bharrhan S, Kuehne AI, Bornholdt ZA, Flyak AI, Saphire EO, Crowe JE, Aman MJ, Dye JM, Lai JR, Chandran K. A "Trojan horse" bispecific-antibody strategy for broad protection against ebolaviruses. Science. 2016 Oct 21; 354(6310):350-354. PMID: 27608667.
      View in: PubMed
    17. Verma A, Basile AO, Bradford Y, Kuivaniemi H, Tromp G, Carey D, Gerhard GS, Crowe JE, Ritchie MD, Pendergrass SA. Phenome-Wide Association Study to Explore Relationships between Immune System Related Genetic Loci and Complex Traits and Diseases. PLoS One. 2016; 11(8):e0160573. PMID: 27508393; PMCID: PMC4980020.
    18. Pallesen J, Murin CD, de Val N, Cottrell CA, Hastie KM, Turner HL, Fusco ML, Flyak AI, Zeitlin L, Crowe JE, Andersen KG, Saphire EO, Ward AB. Structures of Ebola virus GP and sGP in complex with therapeutic antibodies. Nat Microbiol. 2016; 1(9):16128. PMID: 27562261.
      View in: PubMed
    19. Hawman DW, Fox JM, Ashbrook AW, May NA, Schroeder KM, Torres RM, Crowe JE, Dermody TS, Diamond MS, Morrison TE. Pathogenic Chikungunya Virus Evades B Cell Responses to Establish Persistence. Cell Rep. 2016 Aug 2; 16(5):1326-38. PMID: 27452455.
      View in: PubMed
    20. Hicar MD, Chen X, Sulli C, Barnes T, Goodman J, Sojar H, Briney B, Willis J, Chukwuma VU, Kalams SA, Doranz BJ, Spearman P, Crowe JE. Human Antibodies that Recognize Novel Immunodominant Quaternary Epitopes on the HIV-1 Env Protein. PLoS One. 2016; 11(7):e0158861. PMID: 27411063; PMCID: PMC4943599.
    21. Bangaru S, Nieusma T, Kose N, Thornburg NJ, Finn JA, Kaplan BS, King HG, Singh V, Lampley RM, Sapparapu G, Cisneros A, Edwards KM, Slaughter JC, Edupuganti S, Lai L, Richt JA, Webby RJ, Ward AB, Crowe JE. Recognition of influenza H3N2 variant virus by human neutralizing antibodies. JCI Insight. 2016 Jul 07; 1(10). PMID: 27482543.
      View in: PubMed
    22. Sapparapu G, Czakó R, Alvarado G, Shanker S, Prasad BV, Atmar RL, Estes MK, Crowe JE. Frequent Use of the IgA Isotype in Human B Cells Encoding Potent Norovirus-Specific Monoclonal Antibodies That Block HBGA Binding. PLoS Pathog. 2016 Jun; 12(6):e1005719. PMID: 27355511.
      View in: PubMed
    23. Wen X, Pickens J, Mousa JJ, Leser GP, Lamb RA, Crowe JE, Jardetzky TS. A Chimeric Pneumovirus Fusion Protein Carrying Neutralizing Epitopes of Both MPV and RSV. PLoS One. 2016; 11(5):e0155917. PMID: 27224013; PMCID: PMC4880302.
    24. Boehme KW, Ikizler M, Iskarpatyoti JA, Wetzel JD, Willis J, Crowe JE, LaBranche CC, Montefiori DC, Wilson GJ, Dermody TS. Engineering Recombinant Reoviruses To Display gp41 Membrane-Proximal External-Region Epitopes from HIV-1. mSphere. 2016 May-Jun; 1(3). PMID: 27303748; PMCID: PMC4888892.
    25. Finn JA, Koehler Leman J, Willis JR, Cisneros A, Crowe JE, Meiler J. Improving Loop Modeling of the Antibody Complementarity-Determining Region 3 Using Knowledge-Based Restraints. PLoS One. 2016; 11(5):e0154811. PMID: 27182833; PMCID: PMC4868311.
    26. Messer WB, Yount BL, Royal SR, de Alwis R, Widman DG, Smith SA, Crowe JE, Pfaff JM, Kahle KM, Doranz BJ, Ibarra KD, Harris E, de Silva AM, Baric RS. Functional Transplant of a Dengue Virus Serotype 3 (DENV3)-Specific Human Monoclonal Antibody Epitope into DENV1. J Virol. 2016 May 15; 90(10):5090-7. PMID: 26962223; PMCID: PMC4859728 [Available on 10/29/16].
    27. Boyd SD, Crowe JE. Deep sequencing and human antibody repertoire analysis. Curr Opin Immunol. 2016 Jun; 40:103-9. PMID: 27065089.
      View in: PubMed
    28. Willis JR, Finn JA, Briney B, Sapparapu G, Singh V, King H, LaBranche CC, Montefiori DC, Meiler J, Crowe JE. Long antibody HCDR3s from HIV-naïve donors presented on a PG9 neutralizing antibody background mediate HIV neutralization. Proc Natl Acad Sci U S A. 2016 Apr 19; 113(16):4446-51. PMID: 27044078; PMCID: PMC4843476 [Available on 10/19/16].
    29. Ilinykh PA, Shen X, Flyak AI, Kuzmina N, Ksiazek TG, Crowe JE, Bukreyev A. Chimeric Filoviruses for Identification and Characterization of Monoclonal Antibodies. J Virol. 2016 Apr 15; 90(8):3890-901. PMID: 26819310; PMCID: PMC4810552 [Available on 09/28/16].
    30. Thornburg NJ, Zhang H, Bangaru S, Sapparapu G, Kose N, Lampley RM, Bombardi RG, Yu Y, Graham S, Branchizio A, Yoder SM, Rock MT, Creech CB, Edwards KM, Lee D, Li S, Wilson IA, García-Sastre A, Albrecht RA, Crowe JE. H7N9 influenza virus neutralizing antibodies that possess few somatic mutations. J Clin Invest. 2016 Apr 1; 126(4):1482-94. PMID: 26950424; PMCID: PMC4811156.
    31. Bornholdt ZA, Ndungo E, Fusco ML, Bale S, Flyak AI, Crowe JE, Chandran K, Saphire EO. Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies. MBio. 2016; 7(1):e02154-15. PMID: 26908579; PMCID: PMC4791852.
    32. Engelhardt BG, Paczesny S, Jung DK, Daguindau E, Jagasia M, Savani BN, Chinratanalab W, Cornell RF, Goodman S, Greer JP, Kassim AA, Sengsayadeth S, Yoder SM, Rock MT, Crowe JE. Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantation. Haematologica. 2016 May; 101(5):e204-8. PMID: 26819055.
      View in: PubMed
    33. Flyak AI, Shen X, Murin CD, Turner HL, David JA, Fusco ML, Lampley R, Kose N, Ilinykh PA, Kuzmina N, Branchizio A, King H, Brown L, Bryan C, Davidson E, Doranz BJ, Slaughter JC, Sapparapu G, Klages C, Ksiazek TG, Saphire EO, Ward AB, Bukreyev A, Crowe JE. Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection. Cell. 2016 Jan 28; 164(3):392-405. PMID: 26806128; PMCID: PMC4733404 [Available on 01/28/17].
    34. Bates JT, Pickens JA, Schuster JE, Johnson M, Tollefson SJ, Williams JV, Davis NL, Johnston RE, Schultz-Darken N, Slaughter JC, Smith-House F, Crowe JE. Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates. Vaccine. 2016 Feb 10; 34(7):950-6. PMID: 26772634; PMCID: PMC4731299 [Available on 02/10/17].
    35. Alvarado G, Crowe JE. Development of Human Monoclonal Antibodies Against Respiratory Syncytial Virus Using a High Efficiency Human Hybridoma Technique. Methods Mol Biol. 2016; 1442:63-76. PMID: 27464688.
      View in: PubMed
    36. Hicar MD, Chen X, Kalams SA, Sojar H, Landucci G, Forthal DN, Spearman P, Crowe JE. Low frequency of broadly neutralizing HIV antibodies during chronic infection even in quaternary epitope targeting antibodies containing large numbers of somatic mutations. Mol Immunol. 2016 Feb; 70:94-103. PMID: 26748387; PMCID: PMC4762738 [Available on 02/01/17].
    37. Fox JM, Long F, Edeling MA, Lin H, van Duijl-Richter MK, Fong RH, Kahle KM, Smit JM, Jin J, Simmons G, Doranz BJ, Crowe JE, Fremont DH, Rossmann MG, Diamond MS. Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress. Cell. 2015 Nov 19; 163(5):1095-107. PMID: 26553503.
      View in: PubMed
    38. Smith SA, Nivarthi UK, de Alwis R, Kose N, Sapparapu G, Bombardi R, Kahle KM, Pfaff JM, Lieberman S, Doranz BJ, de Silva AM, Crowe JE. Dengue Virus prM-Specific Human Monoclonal Antibodies with Virus Replication-Enhancing Properties Recognize a Single Immunodominant Antigenic Site. J Virol. 2015; 90(2):780-9. PMID: 26512092.
      View in: PubMed
    39. Gallichotte EN, Widman DG, Yount BL, Wahala WM, Durbin A, Whitehead S, Sariol CA, Crowe JE, de Silva AM, Baric RS. A new quaternary structure epitope on dengue virus serotype 2 is the target of durable type-specific neutralizing antibodies. MBio. 2015; 6(5):e01461-15. PMID: 26463165.
      View in: PubMed
    40. Callaway JB, Smith SA, Widman DG, McKinnon KP, Scholle F, Sempowski GD, Dittmer DP, Crowe JE, de Silva AM, Ting JP. Source and Purity of Dengue-Viral Preparations Impact Requirement for Enhancing Antibody to Induce Elevated IL-1? Secretion: A Primary Human Monocyte Model. PLoS One. 2015; 10(8):e0136708. PMID: 26301593.
      View in: PubMed
    41. Crowe JE, Koff WC. Deciphering the human immunome. Expert Rev Vaccines. 2015 Nov; 14(11):1421-5. PMID: 26485213.
      View in: PubMed
    42. Chukwuma VU, Hicar MD, Chen X, Nicholas KJ, Joyner A, Kalams SA, Landucci G, Forthal DN, Spearman PW, Crowe JE. Association of VH4-59 Antibody Variable Gene Usage with Recognition of an Immunodominant Epitope on the HIV-1 Gag Protein. PLoS One. 2015; 10(7):e0133509. PMID: 26226263.
      View in: PubMed
    43. Winarski KL, Thornburg NJ, Yu Y, Sapparapu G, Crowe JE, Spiller BW. Vaccine-elicited antibody that neutralizes H5N1 influenza and variants binds the receptor site and polymorphic sites. Proc Natl Acad Sci U S A. 2015 Jul 28; 112(30):9346-51. PMID: 26170302.
      View in: PubMed
    44. Smith SA, Silva LA, Fox JM, Flyak AI, Kose N, Sapparapu G, Khomandiak S, Khomadiak S, Ashbrook AW, Kahle KM, Fong RH, Swayne S, Doranz BJ, McGee CE, Heise MT, Pal P, Brien JD, Austin SK, Diamond MS, Dermody TS, Crowe JE. Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus. Cell Host Microbe. 2015 Jul 8; 18(1):86-95. PMID: 26159721.
      View in: PubMed
    45. Sevy AM, Jacobs TM, Crowe JE, Meiler J. Design of Protein Multi-specificity Using an Independent Sequence Search Reduces the Barrier to Low Energy Sequences. PLoS Comput Biol. 2015 Jul; 11(7):e1004300. PMID: 26147100.
      View in: PubMed
    46. Fibriansah G, Ibarra KD, Ng TS, Smith SA, Tan JL, Lim XN, Ooi JS, Kostyuchenko VA, Wang J, de Silva AM, Harris E, Crowe JE, Lok SM. DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers. Science. 2015 Jul 3; 349(6243):88-91. PMID: 26138979.
      View in: PubMed
    47. Callaway JB, Smith SA, McKinnon KP, de Silva AM, Crowe JE, Ting JP. Spleen Tyrosine Kinase (Syk) Mediates IL-1? Induction by Primary Human Monocytes during Antibody-enhanced Dengue Virus Infection. J Biol Chem. 2015 Jul 10; 290(28):17306-20. PMID: 26032420.
      View in: PubMed
    48. Willis JR, Sapparapu G, Murrell S, Julien JP, Singh V, King HG, Xia Y, Pickens JA, LaBranche CC, Slaughter JC, Montefiori DC, Wilson IA, Meiler J, Crowe JE. Redesigned HIV antibodies exhibit enhanced neutralizing potency and breadth. J Clin Invest. 2015 Jun; 125(6):2523-31. PMID: 25985274.
      View in: PubMed
    49. Simões EA, DeVincenzo JP, Boeckh M, Bont L, Crowe JE, Griffiths P, Hayden FG, Hodinka RL, Smyth RL, Spencer K, Thirstrup S, Walsh EE, Whitley RJ. Challenges and opportunities in developing respiratory syncytial virus therapeutics. J Infect Dis. 2015 Mar 15; 211 Suppl 1:S1-S20. PMID: 25713060; PMCID: PMC4345819.
    50. Flyak AI, Ilinykh PA, Murin CD, Garron T, Shen X, Fusco ML, Hashiguchi T, Bornholdt ZA, Slaughter JC, Sapparapu G, Klages C, Ksiazek TG, Ward AB, Saphire EO, Bukreyev A, Crowe JE. Mechanism of human antibody-mediated neutralization of Marburg virus. Cell. 2015 Feb 26; 160(5):893-903. PMID: 25723164; PMCID: PMC4344968.
    51. Hashiguchi T, Fusco ML, Bornholdt ZA, Lee JE, Flyak AI, Matsuoka R, Kohda D, Yanagi Y, Hammel M, Crowe JE, Saphire EO. Structural basis for Marburg virus neutralization by a cross-reactive human antibody. Cell. 2015 Feb 26; 160(5):904-12. PMID: 25723165; PMCID: PMC4344967.
    52. Fibriansah G, Tan JL, Smith SA, de Alwis R, Ng TS, Kostyuchenko VA, Jadi RS, Kukkaro P, de Silva AM, Crowe JE, Lok SM. A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins. Nat Commun. 2015; 6:6341. PMID: 25698059; PMCID: PMC4346626.
    53. Smith SA, Crowe JE. Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies. Microbiol Spectr. 2015 Feb; 3(1):AID-0027-2014. PMID: 26104564.
      View in: PubMed
    54. Hooper KA, Crowe JE, Bloom JD. Influenza viruses with receptor-binding N1 neuraminidases occur sporadically in several lineages and show no attenuation in cell culture or mice. J Virol. 2015 Apr; 89(7):3737-45. PMID: 25609803; PMCID: PMC4403400.
    55. Hotard AL, Lee S, Currier MG, Crowe JE, Sakamoto K, Newcomb DC, Peebles RS, Plemper RK, Moore ML. Identification of residues in the human respiratory syncytial virus fusion protein that modulate fusion activity and pathogenesis. J Virol. 2015 Jan; 89(1):512-22. PMID: 25339762; PMCID: PMC4301159.
    56. de Alwis R, Williams KL, Schmid MA, Lai CY, Patel B, Smith SA, Crowe JE, Wang WK, Harris E, de Silva AM. Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera. PLoS Pathog. 2014 Oct; 10(10):e1004386. PMID: 25275316; PMCID: PMC4183589.
    57. Krause JC, Crowe JE. Committing the Oldest Sins in the Newest Kind of Ways-Antibodies Targeting the Influenza Virus Type A Hemagglutinin Globular Head. Microbiol Spectr. 2014 Oct; 2(5). PMID: 26104373.
      View in: PubMed
    58. Smith SA, de Alwis AR, Kose N, Jadi RS, de Silva AM, Crowe JE. Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones. J Virol. 2014 Nov; 88(21):12233-41. PMID: 25100837; PMCID: PMC4248927.
    59. Briney BS, Willis JR, Finn JA, McKinney BA, Crowe JE. Tissue-specific expressed antibody variable gene repertoires. PLoS One. 2014; 9(6):e100839. PMID: 24956460; PMCID: PMC4067404.
    60. Dulek DE, Newcomb DC, Toki S, Goliniewska K, Cephus J, Reiss S, Bates JT, Crowe JE, Boyd KL, Moore ML, Zhou W, Peebles RS. STAT4 deficiency fails to induce lung Th2 or Th17 immunity following primary or secondary respiratory syncytial virus (RSV) challenge but enhances the lung RSV-specific CD8+ T cell immune response to secondary challenge. J Virol. 2014 Sep 1; 88(17):9655-72. PMID: 24920804; PMCID: PMC4136353.
    61. Bates JT, Keefer CJ, Slaughter JC, Kulp DW, Schief WR, Crowe JE. Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein. Virology. 2014 Apr; 454-455:139-44. PMID: 24725940; PMCID: PMC4004766.
    62. Almagro JC, Gilliland GL, Breden F, Scott JK, Sok D, Pauthner M, Reichert JM, Helguera G, Andrabi R, Mabry R, Bléry M, Voss JE, Laurén J, Abuqayyas L, Barghorn S, Ben-Jacob E, Crowe JE, Huston JS, Johnston SA, Krauland E, Lund-Johansen F, Marasco WA, Parren PW, Xu KY. Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CA. MAbs. 2014 May-Jun; 6(3):577-618. PMID: 24589717; PMCID: PMC4011904.
    63. Correia BE, Bates JT, Loomis RJ, Baneyx G, Carrico C, Jardine JG, Rupert P, Correnti C, Kalyuzhniy O, Vittal V, Connell MJ, Stevens E, Schroeter A, Chen M, Macpherson S, Serra AM, Adachi Y, Holmes MA, Li Y, Klevit RE, Graham BS, Wyatt RT, Baker D, Strong RK, Crowe JE, Johnson PR, Schief WR. Proof of principle for epitope-focused vaccine design. Nature. 2014 Mar 13; 507(7491):201-6. PMID: 24499818; PMCID: PMC4260937.
    64. Bisset GS, Crowe J. Diagnostic errors in interpretation of pediatric musculoskeletal radiographs at common injury sites. Pediatr Radiol. 2014 May; 44(5):552-7. PMID: 24445883.
      View in: PubMed
    65. Fibriansah G, Tan JL, Smith SA, de Alwis AR, Ng TS, Kostyuchenko VA, Ibarra KD, Wang J, Harris E, de Silva A, Crowe JE, Lok SM. A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface. EMBO Mol Med. 2014 Mar; 6(3):358-71. PMID: 24421336; PMCID: PMC3958310.
    66. Messer WB, de Alwis R, Yount BL, Royal SR, Huynh JP, Smith SA, Crowe JE, Doranz BJ, Kahle KM, Pfaff JM, White LJ, Sariol CA, de Silva AM, Baric RS. Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity. Proc Natl Acad Sci U S A. 2014 Feb 4; 111(5):1939-44. PMID: 24385585; PMCID: PMC3918811.
    67. Alonas E, Lifland AW, Gudheti M, Vanover D, Jung J, Zurla C, Kirschman J, Fiore VF, Douglas A, Barker TH, Yi H, Wright ER, Crowe JE, Santangelo PJ. Combining single RNA sensitive probes with subdiffraction-limited and live-cell imaging enables the characterization of virus dynamics in cells. ACS Nano. 2014 Jan 28; 8(1):302-15. PMID: 24351207; PMCID: PMC3906890.
    68. Smith SA, de Alwis AR, Kose N, Harris E, Ibarra KD, Kahle KM, Pfaff JM, Xiang X, Doranz BJ, de Silva AM, Austin SK, Sukupolvi-Petty S, Diamond MS, Crowe JE. The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein. MBio. 2013; 4(6):e00873-13. PMID: 24255124; PMCID: PMC3870244.
    69. Sapparapu G, Sims AL, Aiyegbo MS, Shaikh FY, Harth EM, Crowe JE. Intracellular neutralization of a virus using a cell-penetrating molecular transporter. Nanomedicine (Lond). 2014 Aug; 9(11):1613-24. PMID: 24195674.
      View in: PubMed
    70. Aiyegbo MS, Eli IM, Spiller BW, Williams DR, Kim R, Lee DE, Liu T, Li S, Stewart PL, Crowe JE. Differential accessibility of a rotavirus VP6 epitope in trimers comprising type I, II, or III channels as revealed by binding of a human rotavirus VP6-specific antibody. J Virol. 2014 Jan; 88(1):469-76. PMID: 24155406; PMCID: PMC3911710.
    71. Finn JA, Crowe JE. Impact of new sequencing technologies on studies of the human B cell repertoire. Curr Opin Immunol. 2013 Oct; 25(5):613-8. PMID: 24161653; PMCID: PMC3882336.
    72. Munden MM, Williams JL, Zhang W, Crowe JE, Munden RF, Cisek LJ. Intermittent testicular torsion in the pediatric patient: sonographic indicators of a difficult diagnosis. AJR Am J Roentgenol. 2013 Oct; 201(4):912-8. PMID: 24059384.
      View in: PubMed
    73. Hong M, Lee PS, Hoffman RM, Zhu X, Krause JC, Laursen NS, Yoon SI, Song L, Tussey L, Crowe JE, Ward AB, Wilson IA. Antibody recognition of the pandemic H1N1 Influenza virus hemagglutinin receptor binding site. J Virol. 2013 Nov; 87(22):12471-80. PMID: 24027321; PMCID: PMC3807900.
    74. Thornburg NJ, Nannemann DP, Blum DL, Belser JA, Tumpey TM, Deshpande S, Fritz GA, Sapparapu G, Krause JC, Lee JH, Ward AB, Lee DE, Li S, Winarski KL, Spiller BW, Meiler J, Crowe JE. Human antibodies that neutralize respiratory droplet transmissible H5N1 influenza viruses. J Clin Invest. 2013 Oct; 123(10):4405-9. PMID: 23999429; PMCID: PMC3784541.
    75. Crowe JE. Universal flu vaccines: primum non nocere. Sci Transl Med. 2013 Aug 28; 5(200):200fs34. PMID: 23986396.
      View in: PubMed
    76. Stone JW, Thornburg NJ, Blum DL, Kuhn SJ, Wright DW, Crowe JE. Gold nanorod vaccine for respiratory syncytial virus. Nanotechnology. 2013 Jul 26; 24(29):295102. PMID: 23799651; PMCID: PMC3754908.
    77. Crowe JE. Immunology. Crowdsourcing immunity. Science. 2013 May 10; 340(6133):692-3. PMID: 23661747.
      View in: PubMed
    78. Aiyegbo MS, Sapparapu G, Spiller BW, Eli IM, Williams DR, Kim R, Lee DE, Liu T, Li S, Woods VL, Nannemann DP, Meiler J, Stewart PL, Crowe JE. Human rotavirus VP6-specific antibodies mediate intracellular neutralization by binding to a quaternary structure in the transcriptional pore. PLoS One. 2013; 8(5):e61101. PMID: 23671563; PMCID: PMC3650007.
    79. Willis JR, Briney BS, DeLuca SL, Crowe JE, Meiler J. Human germline antibody gene segments encode polyspecific antibodies. PLoS Comput Biol. 2013 Apr; 9(4):e1003045. PMID: 23637590; PMCID: PMC3636087.
    80. Gilchuk P, Spencer CT, Conant SB, Hill T, Gray JJ, Niu X, Zheng M, Erickson JJ, Boyd KL, McAfee KJ, Oseroff C, Hadrup SR, Bennink JR, Hildebrand W, Edwards KM, Crowe JE, Williams JV, Buus S, Sette A, Schumacher TN, Link AJ, Joyce S. Discovering naturally processed antigenic determinants that confer protective T cell immunity. J Clin Invest. 2013 May; 123(5):1976-87. PMID: 23543059; PMCID: PMC3635741.
    81. Smith SA, de Alwis R, Kose N, Durbin AP, Whitehead SS, de Silva AM, Crowe JE. Human monoclonal antibodies derived from memory B cells following live attenuated dengue virus vaccination or natural infection exhibit similar characteristics. J Infect Dis. 2013 Jun 15; 207(12):1898-908. PMID: 23526830; PMCID: PMC3654755.
    82. Bates JT, Keefer CJ, Utley TJ, Correia BE, Schief WR, Crowe JE. Reversion of somatic mutations of the respiratory syncytial virus-specific human monoclonal antibody Fab19 reveal a direct relationship between association rate and neutralizing potency. J Immunol. 2013 Apr 1; 190(7):3732-9. PMID: 23455501; PMCID: PMC3608519.
    83. Xu R, Krause JC, McBride R, Paulson JC, Crowe JE, Wilson IA. A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin. Nat Struct Mol Biol. 2013 Mar; 20(3):363-70. PMID: 23396351; PMCID: PMC3594569.
    84. Zeitlin L, Bohorov O, Bohorova N, Hiatt A, Kim do H, Pauly MH, Velasco J, Whaley KJ, Barnard DL, Bates JT, Crowe JE, Piedra PA, Gilbert BE. Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model. MAbs. 2013 Mar-Apr; 5(2):263-9. PMID: 23396091; PMCID: PMC3893236.
    85. Shaikh FY, Crowe JE. Molecular mechanisms driving respiratory syncytial virus assembly. Future Microbiol. 2013 Jan; 8(1):123-31. PMID: 23252497; PMCID: PMC3577052.
    86. Thornburg NJ, Hayward SL, Crowe JE. Respiratory syncytial virus regulates human microRNAs by using mechanisms involving beta interferon and NF-?B. MBio. 2012; 3(6). PMID: 23249809; PMCID: PMC3529541.
    87. Tsibane T, Ekiert DC, Krause JC, Martinez O, Crowe JE, Wilson IA, Basler CF. Influenza human monoclonal antibody 1F1 interacts with three major antigenic sites and residues mediating human receptor specificity in H1N1 viruses. PLoS Pathog. 2012; 8(12):e1003067. PMID: 23236279; PMCID: PMC3516549.
    88. Benhnia MR, Maybeno M, Blum D, Aguilar-Sino R, Matho M, Meng X, Head S, Felgner PL, Zajonc DM, Koriazova L, Kato S, Burton DR, Xiang Y, Crowe JE, Peters B, Crotty S. Unusual features of vaccinia virus extracellular virion form neutralization resistance revealed in human antibody responses to the smallpox vaccine. J Virol. 2013 Feb; 87(3):1569-85. PMID: 23152530; PMCID: PMC3554146.
    89. Hotard AL, Shaikh FY, Lee S, Yan D, Teng MN, Plemper RK, Crowe JE, Moore ML. A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis. Virology. 2012 Dec 5; 434(1):129-36. PMID: 23062737; PMCID: PMC3492879.
    90. Hayakawa M, Toda N, Carrillo N, Thornburg NJ, Crowe JE, Barbas CF. A chemically programmed antibody is a long-lasting and potent inhibitor of influenza neuraminidase. Chembiochem. 2012 Oct 15; 13(15):2191-5. PMID: 22965667; PMCID: PMC3517015.
    91. Briney BS, Willis JR, Hicar MD, Thomas JW, Crowe JE. Frequency and genetic characterization of V(DD)J recombinants in the human peripheral blood antibody repertoire. Immunology. 2012 Sep; 137(1):56-64. PMID: 22612413; PMCID: PMC3449247.
    92. Engelhardt BG, Sengsayadeth SM, Jagasia M, Savani BN, Kassim AA, Lu P, Shyr Y, Yoder SM, Rock MT, Crowe JE. Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival. Exp Hematol. 2012 Dec; 40(12):974-982.e1. PMID: 22885125; PMCID: PMC3611587.
    93. Crowe JE. Influenza virus resistance to human neutralizing antibodies. MBio. 2012; 3(4):e00213-12. PMID: 22851660; PMCID: PMC3419524.
    94. Shaikh FY, Utley TJ, Craven RE, Rogers MC, Lapierre LA, Goldenring JR, Crowe JE. Respiratory syncytial virus assembles into structured filamentous virion particles independently of host cytoskeleton and related proteins. PLoS One. 2012; 7(7):e40826. PMID: 22808269; PMCID: PMC3396619.
    95. Briney BS, Willis JR, Crowe JE. Location and length distribution of somatic hypermutation-associated DNA insertions and deletions reveals regions of antibody structural plasticity. Genes Immun. 2012 Oct; 13(7):523-9. PMID: 22717702; PMCID: PMC3449029.
    96. Briney BS, Willis JR, McKinney BA, Crowe JE. High-throughput antibody sequencing reveals genetic evidence of global regulation of the naïve and memory repertoires that extends across individuals. Genes Immun. 2012 Sep; 13(6):469-73. PMID: 22622198.
      View in: PubMed
    97. Lifland AW, Jung J, Alonas E, Zurla C, Crowe JE, Santangelo PJ. Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS. J Virol. 2012 Aug; 86(15):8245-58. PMID: 22623778; PMCID: PMC3421640.
    98. Briney BS, Willis JR, Crowe JE. Human peripheral blood antibodies with long HCDR3s are established primarily at original recombination using a limited subset of germline genes. PLoS One. 2012; 7(5):e36750. PMID: 22590602; PMCID: PMC3348910.
    99. de Alwis R, Smith SA, Olivarez NP, Messer WB, Huynh JP, Wahala WM, White LJ, Diamond MS, Baric RS, Crowe JE, de Silva AM. Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. Proc Natl Acad Sci U S A. 2012 May 8; 109(19):7439-44. PMID: 22499787; PMCID: PMC3358852.
    100. Krause JC, Tsibane T, Tumpey TM, Huffman CJ, Albrecht R, Blum DL, Ramos I, Fernandez-Sesma A, Edwards KM, García-Sastre A, Basler CF, Crowe JE. Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses. J Virol. 2012 Jun; 86(11):6334-40. PMID: 22457520; PMCID: PMC3372199.
    101. Wen X, Krause JC, Leser GP, Cox RG, Lamb RA, Williams JV, Crowe JE, Jardetzky TS. Structure of the human metapneumovirus fusion protein with neutralizing antibody identifies a pneumovirus antigenic site. Nat Struct Mol Biol. 2012 Apr; 19(4):461-3. PMID: 22388735; PMCID: PMC3546531.
    102. Shaikh FY, Cox RG, Lifland AW, Hotard AL, Williams JV, Moore ML, Santangelo PJ, Crowe JE. A critical phenylalanine residue in the respiratory syncytial virus fusion protein cytoplasmic tail mediates assembly of internal viral proteins into viral filaments and particles. MBio. 2012; 3(1). PMID: 22318318; PMCID: PMC3280462.
    103. Engelhardt BG, Jagasia SM, Crowe JE, Griffith ML, Savani BN, Kassim AA, Lu P, Weitkamp JH, Moore DJ, Yoder SM, Rock MT, Jagasia M. Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity. Blood. 2012 Mar 8; 119(10):2417-21. PMID: 22262764; PMCID: PMC3311262.
    104. Dochow M, Krumm SA, Crowe JE, Moore ML, Plemper RK. Independent structural domains in paramyxovirus polymerase protein. J Biol Chem. 2012 Feb 24; 287(9):6878-91. PMID: 22215662; PMCID: PMC3307299.
    105. Smith SA, Zhou Y, Olivarez NP, Broadwater AH, de Silva AM, Crowe JE. Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection. J Virol. 2012 Mar; 86(5):2665-75. PMID: 22171265; PMCID: PMC3302281.
    106. Zhang GL, Ansari HR, Bradley P, Cawley GC, Hertz T, Hu X, Jojic N, Kim Y, Kohlbacher O, Lund O, Lundegaard C, Magaret CA, Nielsen M, Papadopoulos H, Raghava GP, Tal VS, Xue LC, Yanover C, Zhu S, Rock MT, Crowe JE, Panayiotou C, Polycarpou MM, Duch W, Brusic V. Machine learning competition in immunology - Prediction of HLA class I binding peptides. J Immunol Methods. 2011 Nov 30; 374(1-2):1-4. PMID: 21986107.
      View in: PubMed
    107. Joyner AS, Willis JR, Crowe JE, Aiken C. Maturation-induced cloaking of neutralization epitopes on HIV-1 particles. PLoS Pathog. 2011 Sep; 7(9):e1002234. PMID: 21931551; PMCID: PMC3169560.
    108. Krause JC, Tsibane T, Tumpey TM, Huffman CJ, Briney BS, Smith SA, Basler CF, Crowe JE. Epitope-specific human influenza antibody repertoires diversify by B cell intraclonal sequence divergence and interclonal convergence. J Immunol. 2011 Oct 1; 187(7):3704-11. PMID: 21880983; PMCID: PMC3178754.
    109. Krause JC, Tsibane T, Tumpey TM, Huffman CJ, Basler CF, Crowe JE. A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin. J Virol. 2011 Oct; 85(20):10905-8. PMID: 21849447; PMCID: PMC3187471.
    110. Rock MT, McKinney BA, Yoder SM, Prudom CE, Wright DW, Crowe JE. Identification of potential human respiratory syncytial virus and metapneumovirus T cell epitopes using computational prediction and MHC binding assays. J Immunol Methods. 2011 Nov 30; 374(1-2):13-7. PMID: 21854782; PMCID: PMC3220792.
    111. Lindquist ME, Mainou BA, Dermody TS, Crowe JE. Activation of protein kinase R is required for induction of stress granules by respiratory syncytial virus but dispensable for viral replication. Virology. 2011 Apr 25; 413(1):103-10. PMID: 21377708; PMCID: PMC3072468.
    112. Schlesinger AE, Crowe JE. Sagittal orientation of ingested coins in the esophagus in children. AJR Am J Roentgenol. 2011 Mar; 196(3):670-2. PMID: 21343512.
      View in: PubMed
    113. Krause JC, Ekiert DC, Tumpey TM, Smith PB, Wilson IA, Crowe JE. An insertion mutation that distorts antibody binding site architecture enhances function of a human antibody. MBio. 2011; 2(1):e00345-10. PMID: 21304166; PMCID: PMC3037006.
    114. Pishchany G, McCoy AL, Torres VJ, Krause JC, Crowe JE, Fabry ME, Skaar EP. Specificity for human hemoglobin enhances Staphylococcus aureus infection. Cell Host Microbe. 2010 Dec 16; 8(6):544-50. PMID: 21147468; PMCID: PMC3032424.
    115. Monsalvo AC, Batalle JP, Lopez MF, Krause JC, Klemenc J, Hernandez JZ, Maskin B, Bugna J, Rubinstein C, Aguilar L, Dalurzo L, Libster R, Savy V, Baumeister E, Aguilar L, Cabral G, Font J, Solari L, Weller KP, Johnson J, Echavarria M, Edwards KM, Chappell JD, Crowe JE, Williams JV, Melendi GA, Polack FP. Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat Med. 2011 Feb; 17(2):195-9. PMID: 21131958; PMCID: PMC3034774.
    116. Thornburg NJ, Shepherd B, Crowe JE. Transforming growth factor beta is a major regulator of human neonatal immune responses following respiratory syncytial virus infection. J Virol. 2010 Dec; 84(24):12895-902. PMID: 20926560; PMCID: PMC3004333.
    117. Lindquist ME, Lifland AW, Utley TJ, Santangelo PJ, Crowe JE. Respiratory syncytial virus induces host RNA stress granules to facilitate viral replication. J Virol. 2010 Dec; 84(23):12274-84. PMID: 20844027; PMCID: PMC2976418.
    118. Davis NA, Crowe JE, Pajewski NM, McKinney BA. Surfing a genetic association interaction network to identify modulators of antibody response to smallpox vaccine. Genes Immun. 2010 Dec; 11(8):630-6. PMID: 20613780; PMCID: PMC3001955.
    119. Hicar MD, Chen X, Briney B, Hammonds J, Wang JJ, Kalams S, Spearman PW, Crowe JE. Pseudovirion particles bearing native HIV envelope trimers facilitate a novel method for generating human neutralizing monoclonal antibodies against HIV. J Acquir Immune Defic Syndr. 2010 Jul; 54(3):223-35. PMID: 20531016; PMCID: PMC2930513.
    120. Williams JV, Edwards KM, Weinberg GA, Griffin MR, Hall CB, Zhu Y, Szilagyi PG, Wang CK, Yang CF, Silva D, Ye D, Spaete RR, Crowe JE. Population-based incidence of human metapneumovirus infection among hospitalized children. J Infect Dis. 2010 Jun 15; 201(12):1890-8. PMID: 20446850; PMCID: PMC2873123.
    121. Engelhardt BG, Jagasia M, Savani BN, Bratcher NL, Greer JP, Jiang A, Kassim AA, Lu P, Schuening F, Yoder SM, Rock MT, Crowe JE. Regulatory T cell expression of CLA or ?(4)?(7) and skin or gut acute GVHD outcomes. Bone Marrow Transplant. 2011 Mar; 46(3):436-42. PMID: 20577222; PMCID: PMC3217583.
    122. Hicar MD, Kalams SA, Spearman PW, Crowe JE. Emerging studies of human HIV-specific antibody repertoires. Vaccine. 2010 May 26; 28 Suppl 2:B18-23. PMID: 20510738; PMCID: PMC2879399.
    123. Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE, Wilson IA. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science. 2010 Apr 16; 328(5976):357-60. PMID: 20339031; PMCID: PMC2897825.
    124. Engelhardt BG, Crowe JE. Homing in on acute graft vs. host disease: tissue-specific T regulatory and Th17 cells. Curr Top Microbiol Immunol. 2010; 341:121-46. PMID: 20563712; PMCID: PMC3793903.
    125. Crowe JE. Recent advances in the study of human antibody responses to influenza virus using optimized human hybridoma approaches. Vaccine. 2009 Dec 30; 27 Suppl 6:G47-51. PMID: 20006140; PMCID: PMC2835990.
    126. Krause JC, Tumpey TM, Huffman CJ, McGraw PA, Pearce MB, Tsibane T, Hai R, Basler CF, Crowe JE. Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses. J Virol. 2010 Mar; 84(6):3127-30. PMID: 20042511; PMCID: PMC2826039.
    127. Williams JV, Weitkamp JH, Blum DL, LaFleur BJ, Crowe JE. The human neonatal B cell response to respiratory syncytial virus uses a biased antibody variable gene repertoire that lacks somatic mutations. Mol Immunol. 2009 Dec; 47(2-3):407-14. PMID: 19804909; PMCID: PMC2788105.
    128. Yang CF, Wang CK, Tollefson SJ, Piyaratna R, Lintao LD, Chu M, Liem A, Mark M, Spaete RR, Crowe JE, Williams JV. Genetic diversity and evolution of human metapneumovirus fusion protein over twenty years. Virol J. 2009; 6:138. PMID: 19740442; PMCID: PMC2753315.
    129. Talbot HK, Shepherd BE, Crowe JE, Griffin MR, Edwards KM, Podsiad AB, Tollefson SJ, Wright PF, Williams JV. The pediatric burden of human coronaviruses evaluated for twenty years. Pediatr Infect Dis J. 2009 Aug; 28(8):682-7. PMID: 19633513; PMCID: PMC2765860.
    130. Talbot HK, Crowe JE, Edwards KM, Griffin MR, Zhu Y, Weinberg GA, Szilagyi PG, Hall CB, Podsiad AB, Iwane M, Williams JV. Coronavirus infection and hospitalizations for acute respiratory illness in young children. J Med Virol. 2009 May; 81(5):853-6. PMID: 19319948; PMCID: PMC2767383.
    131. Santangelo PJ, Lifland AW, Curt P, Sasaki Y, Bassell GJ, Lindquist ME, Crowe JE. Single molecule-sensitive probes for imaging RNA in live cells. Nat Methods. 2009 May; 6(5):347-9. PMID: 19349979; PMCID: PMC4297622.
    132. McKinney BA, Crowe JE, Guo J, Tian D. Capturing the spectrum of interaction effects in genetic association studies by simulated evaporative cooling network analysis. PLoS Genet. 2009 Mar; 5(3):e1000432. PMID: 19300503; PMCID: PMC2653647.
    133. Moore ML, Chi MH, Luongo C, Lukacs NW, Polosukhin VV, Huckabee MM, Newcomb DC, Buchholz UJ, Crowe JE, Goleniewska K, Williams JV, Collins PL, Peebles RS. A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction. J Virol. 2009 May; 83(9):4185-94. PMID: 19211758; PMCID: PMC2668460.
    134. Nam KT, Lee HJ, Mok H, Romero-Gallo J, Crowe JE, Peek RM, Goldenring JR. Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia. Gastroenterology. 2009 Apr; 136(4):1288-96. PMID: 19230855; PMCID: PMC2844775.
    135. Derdowski A, Peters TR, Glover N, Qian R, Utley TJ, Burnett A, Williams JV, Spearman P, Crowe JE. Human metapneumovirus nucleoprotein and phosphoprotein interact and provide the minimal requirements for inclusion body formation. J Gen Virol. 2008 Nov; 89(Pt 11):2698-708. PMID: 18931065; PMCID: PMC2876975.
    136. Reif DM, Motsinger-Reif AA, McKinney BA, Rock MT, Crowe JE, Moore JH. Integrated analysis of genetic and proteomic data identifies biomarkers associated with adverse events following smallpox vaccination. Genes Immun. 2009 Mar; 10(2):112-9. PMID: 18923431; PMCID: PMC2692715.
    137. Mok H, Tollefson SJ, Podsiad AB, Shepherd BE, Polosukhin VV, Johnston RE, Williams JV, Crowe JE. An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats. J Virol. 2008 Nov; 82(22):11410-8. PMID: 18786987; PMCID: PMC2573258.
    138. Yu X, Tsibane T, McGraw PA, House FS, Keefer CJ, Hicar MD, Tumpey TM, Pappas C, Perrone LA, Martinez O, Stevens J, Wilson IA, Aguilar PV, Altschuler EL, Basler CF, Crowe JE. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature. 2008 Sep 25; 455(7212):532-6. PMID: 18716625; PMCID: PMC2848880.
    139. Mok H, Lee S, Wright DW, Crowe JE. Enhancement of the CD8+ T cell response to a subdominant epitope of respiratory syncytial virus by deletion of an immunodominant epitope. Vaccine. 2008 Sep 2; 26(37):4775-82. PMID: 18662734; PMCID: PMC2561208.
    140. Utley TJ, Ducharme NA, Varthakavi V, Shepherd BE, Santangelo PJ, Lindquist ME, Goldenring JR, Crowe JE. Respiratory syncytial virus uses a Vps4-independent budding mechanism controlled by Rab11-FIP2. Proc Natl Acad Sci U S A. 2008 Jul 22; 105(29):10209-14. PMID: 18621683; PMCID: PMC2481327.
    141. Reif DM, McKinney BA, Motsinger AA, Chanock SJ, Edwards KM, Rock MT, Moore JH, Crowe JE. Genetic basis for adverse events after smallpox vaccination. J Infect Dis. 2008 Jul 1; 198(1):16-22. PMID: 18454680; PMCID: PMC2746083.
    142. Yu X, McGraw PA, House FS, Crowe JE. An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies. J Immunol Methods. 2008 Jul 31; 336(2):142-51. PMID: 18514220; PMCID: PMC2519117.
    143. Kallewaard NL, McKinney BA, Gu Y, Chen A, Prasad BV, Crowe JE. Functional maturation of the human antibody response to rotavirus. J Immunol. 2008 Mar 15; 180(6):3980-9. PMID: 18322207.
      View in: PubMed
    144. Tian C, Luskin GK, Dischert KM, Higginbotham JN, Shepherd BE, Crowe JE. Immunodominance of the VH1-46 antibody gene segment in the primary repertoire of human rotavirus-specific B cells is reduced in the memory compartment through somatic mutation of nondominant clones. J Immunol. 2008 Mar 1; 180(5):3279-88. PMID: 18292552.
      View in: PubMed
    145. Mok H, Lee S, Utley TJ, Shepherd BE, Polosukhin VV, Collier ML, Davis NL, Johnston RE, Crowe JE. Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats. J Virol. 2007 Dec; 81(24):13710-22. PMID: 17928349; PMCID: PMC2168850.
    146. McKinney BA, Kallewaard NL, Crowe JE, Meiler J. Using the natural evolution of a rotavirus-specific human monoclonal antibody to predict the complex topography of a viral antigenic site. Immunome Res. 2007; 3:8. PMID: 17877819; PMCID: PMC2042970.
    147. McKinney BA, Reif DM, White BC, Crowe JE, Moore JH. Evaporative cooling feature selection for genotypic data involving interactions. Bioinformatics. 2007 Aug 15; 23(16):2113-20. PMID: 17586549; PMCID: PMC3988427.
    148. Crowe JE. Genetic predisposition for adverse events after vaccination. J Infect Dis. 2007 Jul 15; 196(2):176-7. PMID: 17570102.
      View in: PubMed
    149. Williams JV, Chen Z, Cseke G, Wright DW, Keefer CJ, Tollefson SJ, Hessell A, Podsiad A, Shepherd BE, Sanna PP, Burton DR, Crowe JE, Williamson RA. A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo. J Virol. 2007 Aug; 81(15):8315-24. PMID: 17522220; PMCID: PMC1951312.
    150. Greenbaum JA, Andersen PH, Blythe M, Bui HH, Cachau RE, Crowe J, Davies M, Kolaskar AS, Lund O, Morrison S, Mumey B, Ofran Y, Pellequer JL, Pinilla C, Ponomarenko JV, Raghava GP, van Regenmortel MH, Roggen EL, Sette A, Schlessinger A, Sollner J, Zand M, Peters B. Towards a consensus on datasets and evaluation metrics for developing B-cell epitope prediction tools. J Mol Recognit. 2007 Mar-Apr; 20(2):75-82. PMID: 17205610.
      View in: PubMed
    151. Tian C, Luskin GK, Dischert KM, Higginbotham JN, Shepherd BE, Crowe JE. Evidence for preferential Ig gene usage and differential TdT and exonuclease activities in human naïve and memory B cells. Mol Immunol. 2007 Mar; 44(9):2173-83. PMID: 17196657; PMCID: PMC1859862.
    152. Lee S, Miller SA, Wright DW, Rock MT, Crowe JE. Tissue-specific regulation of CD8+ T-lymphocyte immunodominance in respiratory syncytial virus infection. J Virol. 2007 Mar; 81(5):2349-58. PMID: 17182672; PMCID: PMC1865932.
    153. Cseke G, Wright DW, Tollefson SJ, Johnson JE, Crowe JE, Williams JV. Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats. J Virol. 2007 Jan; 81(2):698-707. PMID: 17050599; PMCID: PMC1797435.
    154. Miller SA, Tollefson S, Crowe JE, Williams JV, Wright DW. Examination of a fusogenic hexameric core from human metapneumovirus and identification of a potent synthetic peptide inhibitor from the heptad repeat 1 region. J Virol. 2007 Jan; 81(1):141-9. PMID: 17035305; PMCID: PMC1797239.
    155. McKinney BA, Reif DM, Rock MT, Edwards KM, Kingsmore SF, Moore JH, Crowe JE. Cytokine expression patterns associated with systemic adverse events following smallpox immunization. J Infect Dis. 2006 Aug 15; 194(4):444-53. PMID: 16845627; PMCID: PMC1620015.
    156. Rock MT, Yoder SM, Talbot TR, Edwards KM, Crowe JE. Cellular immune responses to diluted and undiluted aventis pasteur smallpox vaccine. J Infect Dis. 2006 Aug 15; 194(4):435-43. PMID: 16845626.
      View in: PubMed
    157. Tian C, Kron GK, Dischert KM, Higginbotham JN, Crowe JE. Low expression of the interleukin (IL)-4 receptor alpha chain and reduced signalling via the IL-4 receptor complex in human neonatal B cells. Immunology. 2006 Sep; 119(1):54-62. PMID: 16764687; PMCID: PMC1782340.
    158. Venkataraman S, Allison DP, Qi H, Morrell-Falvey JL, Kallewaard NL, Crowe JE, Doktycz MJ. Automated image analysis of atomic force microscopy images of rotavirus particles. Ultramicroscopy. 2006 Jun-Jul; 106(8-9):829-37. PMID: 16730407.
      View in: PubMed
    159. Weitkamp JH, Lafleur BJ, Crowe JE. Rotavirus-specific CD5+ B cells in young children exhibit a distinct antibody repertoire compared with CD5- B cells. Hum Immunol. 2006 Jan-Feb; 67(1-2):33-42. PMID: 16698423.
      View in: PubMed
    160. Bowen AL, Tian C, LaFleur BJ, Crowe JE. Transcriptional control of activation-induced cytidine deaminase and error-prone DNA polymerases is functionally mature in the B cells of infants at birth. Hum Immunol. 2006 Jan-Feb; 67(1-2):43-6. PMID: 16698424.
      View in: PubMed
    161. McKinney BA, Crowe JE, Voss HU, Crooke PS, Barney N, Moore JH. Hybrid grammar-based approach to nonlinear dynamical system identification from biological time series. Phys Rev E Stat Nonlin Soft Matter Phys. 2006 Feb; 73(2 Pt 1):021912. PMID: 16605367.
      View in: PubMed
    162. Williams JV, Wang CK, Yang CF, Tollefson SJ, House FS, Heck JM, Chu M, Brown JB, Lintao LD, Quinto JD, Chu D, Spaete RR, Edwards KM, Wright PF, Crowe JE. The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience. J Infect Dis. 2006 Feb 1; 193(3):387-95. PMID: 16388486; PMCID: PMC1586246.
    163. Martino R, Porras RP, Rabella N, Williams JV, Rámila E, Margall N, Labeaga R, Crowe JE, Coll P, Sierra J. Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biol Blood Marrow Transplant. 2005 Oct; 11(10):781-96. PMID: 16182179; PMCID: PMC3347977.
    164. Brock SC, Heck JM, McGraw PA, Crowe JE. The transmembrane domain of the respiratory syncytial virus F protein is an orientation-independent apical plasma membrane sorting sequence. J Virol. 2005 Oct; 79(19):12528-35. PMID: 16160180; PMCID: PMC1211512.
    165. Williams JV, Tollefson SJ, Johnson JE, Crowe JE. The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity. J Virol. 2005 Sep; 79(17):10944-51. PMID: 16103146; PMCID: PMC1193579.
    166. Williams JV, Crowe JE, Enriquez R, Minton P, Peebles RS, Hamilton RG, Higgins S, Griffin M, Hartert TV. Human metapneumovirus infection plays an etiologic role in acute asthma exacerbations requiring hospitalization in adults. J Infect Dis. 2005 Oct 1; 192(7):1149-53. PMID: 16136455; PMCID: PMC1476781.
    167. Williams JV, Martino R, Rabella N, Otegui M, Parody R, Heck JM, Crowe JE. A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. J Infect Dis. 2005 Sep 15; 192(6):1061-5. PMID: 16107960; PMCID: PMC1483060.
    168. Rutigliano JA, Rock MT, Johnson AK, Crowe JE, Graham BS. Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus. Virology. 2005 Jul 5; 337(2):335-43. PMID: 15916793.
      View in: PubMed
    169. Williams JV, Tollefson SJ, Heymann PW, Carper HT, Patrie J, Crowe JE. Human metapneumovirus infection in children hospitalized for wheezing. J Allergy Clin Immunol. 2005 Jun; 115(6):1311-2. PMID: 15940152; PMCID: PMC1476700.
    170. Weitkamp JH, Lafleur BJ, Greenberg HB, Crowe JE. Natural evolution of a human virus-specific antibody gene repertoire by somatic hypermutation requires both hotspot-directed and randomly-directed processes. Hum Immunol. 2005 Jun; 66(6):666-76. PMID: 15993712.
      View in: PubMed
    171. Chen X, Rock MT, Hammonds J, Tartaglia J, Shintani A, Currier J, Slike B, Crowe JE, Marovich M, Spearman P. Pseudovirion particle production by live poxvirus human immunodeficiency virus vaccine vector enhances humoral and cellular immune responses. J Virol. 2005 May; 79(9):5537-47. PMID: 15827168; PMCID: PMC1082749.
    172. Bentzen EL, House F, Utley TJ, Crowe JE, Wright DW. Progression of respiratory syncytial virus infection monitored by fluorescent quantum dot probes. Nano Lett. 2005 Apr; 5(4):591-5. PMID: 15826092.
      View in: PubMed
    173. Weitkamp JH, Kallewaard NL, Bowen AL, Lafleur BJ, Greenberg HB, Crowe JE. VH1-46 is the dominant immunoglobulin heavy chain gene segment in rotavirus-specific memory B cells expressing the intestinal homing receptor alpha4beta7. J Immunol. 2005 Mar 15; 174(6):3454-60. PMID: 15749880.
      View in: PubMed
    174. Rock MT, Yoder SM, Wright PF, Talbot TR, Edwards KM, Crowe JE. Differential regulation of granzyme and perforin in effector and memory T cells following smallpox immunization. J Immunol. 2005 Mar 15; 174(6):3757-64. PMID: 15749916.
      View in: PubMed
    175. Tai JH, Williams JV, Edwards KM, Wright PF, Crowe JE, Dermody TS. Prevalence of reovirus-specific antibodies in young children in Nashville, Tennessee. J Infect Dis. 2005 Apr 15; 191(8):1221-4. PMID: 15776366.
      View in: PubMed
    176. Shaklee JF, Talbot TR, Muldowney JA, Vaughan DE, Butler J, House F, Crowe JE, Smith LH, Edwards KM. Smallpox vaccination does not elevate systemic levels of prothrombotic proteins associated with ischemic cardiac events. J Infect Dis. 2005 Mar 1; 191(5):724-30. PMID: 15688286.
      View in: PubMed
    177. Kallewaard NL, Bowen AL, Crowe JE. Cooperativity of actin and microtubule elements during replication of respiratory syncytial virus. Virology. 2005 Jan 5; 331(1):73-81. PMID: 15582654.
      View in: PubMed
    178. Crowe JE. Human metapneumovirus as a major cause of human respiratory tract disease. Pediatr Infect Dis J. 2004 Nov; 23(11 Suppl):S215-21. PMID: 15577576.
      View in: PubMed
    179. Talbot TR, Stapleton JT, Brady RC, Winokur PL, Bernstein DI, Germanson T, Yoder SM, Rock MT, Crowe JE, Edwards KM. Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial. JAMA. 2004 Sep 8; 292(10):1205-12. PMID: 15353533.
      View in: PubMed
    180. Kelleher T, Ryan E, Barrett S, Sweeney M, Byrnes V, O'Keane C, Crowe J. Increased DMT1 but not IREG1 or HFE mRNA following iron depletion therapy in hereditary haemochromatosis. Gut. 2004 Aug; 53(8):1174-9. PMID: 15247188; PMCID: PMC1774138.
    181. Rock MT, Yoder SM, Talbot TR, Edwards KM, Crowe JE. Adverse events after smallpox immunizations are associated with alterations in systemic cytokine levels. J Infect Dis. 2004 Apr 15; 189(8):1401-10. PMID: 15073677.
      View in: PubMed
    182. Suara RO, Crowe JE. Effect of zinc salts on respiratory syncytial virus replication. Antimicrob Agents Chemother. 2004 Mar; 48(3):783-90. PMID: 14982765; PMCID: PMC353050.
    183. Williams JV, Harris PA, Tollefson SJ, Halburnt-Rush LL, Pingsterhaus JM, Edwards KM, Wright PF, Crowe JE. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med. 2004 Jan 29; 350(5):443-50. PMID: 14749452; PMCID: PMC1831873.
    184. Brock SC, Goldenring JR, Crowe JE. Apical recycling systems regulate directional budding of respiratory syncytial virus from polarized epithelial cells. Proc Natl Acad Sci U S A. 2003 Dec 9; 100(25):15143-8. PMID: 14630951; PMCID: PMC299925.
    185. Weitkamp JH, Kallewaard N, Kusuhara K, Bures E, Williams JV, LaFleur B, Greenberg HB, Crowe JE. Infant and adult human B cell responses to rotavirus share common immunodominant variable gene repertoires. J Immunol. 2003 Nov 1; 171(9):4680-8. PMID: 14568943.
      View in: PubMed
    186. Halasa NB, Whitlock JA, McCurley TL, Smith JA, Zhu Q, Ochs H, Dermody TS, Crowe JE. Fatal hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infection in a patient with a novel mutation in the signaling lymphocytic activation molecule-associated protein. Clin Infect Dis. 2003 Nov 15; 37(10):e136-41. PMID: 14583885.
      View in: PubMed
    187. Barrett S, Collins M, Kenny C, Ryan E, Keane CO, Crowe J. Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection. J Med Virol. 2003 Oct; 71(2):212-8. PMID: 12938195.
      View in: PubMed
    188. Venter M, Rock M, Puren AJ, Tiemessen CT, Crowe JE. Respiratory syncytial virus nucleoprotein-specific cytotoxic T-cell epitopes in a South African population of diverse HLA types are conserved in circulating field strains. J Virol. 2003 Jul; 77(13):7319-29. PMID: 12805430; PMCID: PMC164818.
    189. Crowe JE, Sannella EC, Pfeiffer S, Zorn GL, Azimzadeh A, Newman R, Miller GG, Pierson RN. CD154 regulates primate humoral immunity to influenza. Am J Transplant. 2003 Jun; 3(6):680-8. PMID: 12780559.
      View in: PubMed
    190. Crowe JE, Williams JV. Immunology of viral respiratory tract infection in infancy. Paediatr Respir Rev. 2003 Jun; 4(2):112-9. PMID: 12758048.
      View in: PubMed
    191. Rock MT, Crowe JE. Identification of a novel human leucocyte antigen-A*01-restricted cytotoxic T-lymphocyte epitope in the respiratory syncytial virus fusion protein. Immunology. 2003 Apr; 108(4):474-80. PMID: 12667209; PMCID: PMC1782928.
    192. Weitkamp JH, Kallewaard N, Kusuhara K, Feigelstock D, Feng N, Greenberg HB, Crowe JE. Generation of recombinant human monoclonal antibodies to rotavirus from single antigen-specific B cells selected with fluorescent virus-like particles. J Immunol Methods. 2003 Apr 1; 275(1-2):223-37. PMID: 12667686.
      View in: PubMed
    193. Brock SC, McGraw PA, Wright PF, Crowe JE. The human polymeric immunoglobulin receptor facilitates invasion of epithelial cells by Streptococcus pneumoniae in a strain-specific and cell type-specific manner. Infect Immun. 2002 Sep; 70(9):5091-5. PMID: 12183558; PMCID: PMC128237.
    194. Peters TR, Jennings MT, Crowe JE. Pneumocystis carinii pneumonia in a girl with a midbrain glioma. Pediatr Hematol Oncol. 2002 Mar; 19(2):141-3. PMID: 11881789.
      View in: PubMed
    195. Crowe JE. Respiratory syncytial virus vaccine development. Vaccine. 2001 Oct 15; 20 Suppl 1:S32-7. PMID: 11587807.
      View in: PubMed
    196. Crowe JE. Influence of maternal antibodies on neonatal immunization against respiratory viruses. Clin Infect Dis. 2001 Nov 15; 33(10):1720-7. PMID: 11595986.
      View in: PubMed
    197. Crowe JE, Firestone CY, Murphy BR. Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines. J Immunol. 2001 Oct 1; 167(7):3910-8. PMID: 11564809.
      View in: PubMed
    198. Weitkamp JH, Crowe JE. Blood donor leukocyte reduction filters as a source of human B lymphocytes. Biotechniques. 2001 Sep; 31(3):464, 466. PMID: 11570486.
      View in: PubMed
    199. Pierson RN, Crowe JE, Pfeiffer S, Atkinson J, Azimzadeh A, Miller GG. CD40-ligand in primate cardiac allograft and viral immunity. Immunol Res. 2001; 23(2-3):253-62. PMID: 11444390.
      View in: PubMed
    200. Crowe JE, Suara RO, Brock S, Kallewaard N, House F, Weitkamp JH. Genetic and structural determinants of virus neutralizing antibodies. Immunol Res. 2001; 23(2-3):135-45. PMID: 11444379.
      View in: PubMed
    201. Peters M, Crowe J, Piéri JF, Quartero H, Hayes-Gill B, James D, Stinstra J, Shakespeare S. Monitoring the fetal heart non-invasively: a review of methods. J Perinat Med. 2001; 29(5):408-16. PMID: 11723842.
      View in: PubMed
    202. Weitkamp JH, Tang YW, Haas DW, Midha NK, Crowe JE. Recurrent Achromobacter xylosoxidans bacteremia associated with persistent lymph node infection in a patient with hyper-immunoglobulin M syndrome. Clin Infect Dis. 2000 Nov; 31(5):1183-7. PMID: 11073750.
      View in: PubMed
    203. Peters TR, Brumbaugh DE, Lawton AR, Crowe JE. Recurrent pneumococcal arthritis as the presenting manifestation of X-linked agammaglobulinemia. Clin Infect Dis. 2000 Nov; 31(5):1287-8. PMID: 11073766.
      View in: PubMed
    204. Wright PF, Karron RA, Belshe RB, Thompson J, Crowe JE, Boyce TG, Halburnt LL, Reed GW, Whitehead SS, Anderson EL, Wittek AE, Casey R, Eichelberger M, Thumar B, Randolph VB, Udem SA, Chanock RM, Murphy BR. Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. J Infect Dis. 2000 Nov; 182(5):1331-42. PMID: 11010838.
      View in: PubMed
    205. Pastey MK, Gower TL, Spearman PW, Crowe JE, Graham BS. A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3. Nat Med. 2000 Jan; 6(1):35-40. PMID: 10613821.
      View in: PubMed
    206. Hegamin-Younger C, Piven ML, Buckwalter KC, Schacht E, Brems CS, Hradek E, Keen P, Morris W, Crowe JE. Use of the Iowa Self-Assessment Inventory with older hospitalized patients. J Gerontol Nurs. 1999 Nov; 25(11):44-9. PMID: 10776162.
      View in: PubMed
    207. Fisher RG, Crowe JE, Johnson TR, Tang YW, Graham BS. Passive IgA monoclonal antibody is no more effective than IgG at protecting mice from mucosal challenge with respiratory syncytial virus. J Infect Dis. 1999 Oct; 180(4):1324-7. PMID: 10479165.
      View in: PubMed
    208. Pastey MK, Crowe JE, Graham BS. RhoA interacts with the fusion glycoprotein of respiratory syncytial virus and facilitates virus-induced syncytium formation. J Virol. 1999 Sep; 73(9):7262-70. PMID: 10438814; PMCID: PMC104251.
    209. Sakurai H, Williamson RA, Crowe JE, Beeler JA, Poignard P, Bastidas RB, Chanock RM, Burton DR. Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines. J Virol. 1999 Apr; 73(4):2956-62. PMID: 10074145; PMCID: PMC104055.
    210. Whitehead SS, Firestone CY, Karron RA, Crowe JE, Elkins WR, Collins PL, Murphy BR. Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts530/1030 to RSV vaccine candidate cpts248/404 increases its attenuation and temperature sensitivity. J Virol. 1999 Feb; 73(2):871-7. PMID: 9882287; PMCID: PMC103906.
    211. Crowe JE, Randolph V, Murphy BR. The live attenuated subgroup B respiratory syncytial virus vaccine candidate RSV 2B33F is attenuated and immunogenic in chimpanzees, but exhibits partial loss of the ts phenotype following replication in vivo. Virus Res. 1999 Jan; 59(1):13-22. PMID: 10854162.
      View in: PubMed
    212. Crowe JE. Host responses to respiratory virus infection and immunization. Curr Top Microbiol Immunol. 1999; 236:191-214. PMID: 9893361.
      View in: PubMed
    213. Crowe JE, Firestone CY, Crim R, Beeler JA, Coelingh KL, Barbas CF, Burton DR, Chanock RM, Murphy BR. Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein. Virology. 1998 Dec 20; 252(2):373-5. PMID: 9878616.
      View in: PubMed
    214. Crowe JE. Immune responses of infants to infection with respiratory viruses and live attenuated respiratory virus candidate vaccines. Vaccine. 1998 Aug-Sep; 16(14-15):1423-32. PMID: 9711783.
      View in: PubMed
    215. Crowe JE, Gilmour PS, Murphy BR, Chanock RM, Duan L, Pomerantz RJ, Pilkington GR. Isolation of a second recombinant human respiratory syncytial virus monoclonal antibody fragment (Fab RSVF2-5) that exhibits therapeutic efficacy in vivo. J Infect Dis. 1998 Apr; 177(4):1073-6. PMID: 9534985.
      View in: PubMed
    216. Karron RA, Wright PF, Crowe JE, Clements-Mann ML, Thompson J, Makhene M, Casey R, Murphy BR. Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children. J Infect Dis. 1997 Dec; 176(6):1428-36. PMID: 9395351.
      View in: PubMed
    217. Juhasz K, Whitehead SS, Bui PT, Biggs JM, Crowe JE, Boulanger CA, Collins PL, Murphy BR. The temperature-sensitive (ts) phenotype of a cold-passaged (cp) live attenuated respiratory syncytial virus vaccine candidate, designated cpts530, results from a single amino acid substitution in the L protein. J Virol. 1997 Aug; 71(8):5814-9. PMID: 9223470; PMCID: PMC191836.
    218. Firestone CY, Whitehead SS, Collins PL, Murphy BR, Crowe JE. Nucleotide sequence analysis of the respiratory syncytial virus subgroup A cold-passaged (cp) temperature sensitive (ts) cpts-248/404 live attenuated virus vaccine candidate. Virology. 1996 Nov 15; 225(2):419-22. PMID: 8918930.
      View in: PubMed
    219. Crowe JE, Bui PT, Firestone CY, Connors M, Elkins WR, Chanock RM, Murphy BR. Live subgroup B respiratory syncytial virus vaccines that are attenuated, genetically stable, and immunogenic in rodents and nonhuman primates. J Infect Dis. 1996 Apr; 173(4):829-39. PMID: 8603960.
      View in: PubMed
    220. Crowe J, Masone BS, Ribbe J. One-step purification of recombinant proteins with the 6xHis tag and Ni-NTA resin. Methods Mol Biol. 1996; 58:491-510. PMID: 8713899.
      View in: PubMed
    221. Crowe JE, Firestone CY, Whitehead SS, Collins PL, Murphy BR. Acquisition of the ts phenotype by a chemically mutagenized cold-passaged human respiratory syncytial virus vaccine candidate results from the acquisition of a single mutation in the polymerase (L) gene. Virus Genes. 1996; 13(3):269-73. PMID: 9035372.
      View in: PubMed
    222. Crowe JE, Bui PT, Siber GR, Elkins WR, Chanock RM, Murphy BR. Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization. Vaccine. 1995 Jun; 13(9):847-55. PMID: 7483808.
      View in: PubMed
    223. Connors M, Crowe JE, Firestone CY, Murphy BR, Collins PL. A cold-passaged, attenuated strain of human respiratory syncytial virus contains mutations in the F and L genes. Virology. 1995 Apr 20; 208(2):478-84. PMID: 7747420.
      View in: PubMed
    224. Hsu KH, Crowe JE, Lubeck MD, Davis AR, Hung PP, Chanock RM, Murphy BR. Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus. Vaccine. 1995 Apr; 13(5):509-15. PMID: 7543716.
      View in: PubMed
    225. Crowe JE. Current approaches to the development of vaccines against disease caused by respiratory syncytial virus (RSV) and parainfluenza virus (PIV). A meeting report of the WHO Programme for Vaccine Development. Vaccine. 1995 Mar; 13(4):415-21. PMID: 7793140.
      View in: PubMed
    226. Kulkarni AB, Collins PL, Bacik I, Yewdell JW, Bennink JR, Crowe JE, Murphy BR. Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus. J Virol. 1995 Feb; 69(2):1261-4. PMID: 7815502; PMCID: PMC188700.
    227. Crowe JE, Cheung PY, Wallace EF, Chanock RM, Larrick JW, Murphy BR, Fry K. Isolation and characterization of a chimpanzee monoclonal antibody to the G glycoprotein of human respiratory syncytial virus. Clin Diagn Lab Immunol. 1994 Nov; 1(6):701-6. PMID: 8556524; PMCID: PMC368396.
    228. Crowe JE, Bui PT, Davis AR, Chanock RM, Murphy BR. A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees. Vaccine. 1994 Jul; 12(9):783-90. PMID: 7975856.
      View in: PubMed
    229. Crowe JE, Bui PT, London WT, Davis AR, Hung PP, Chanock RM, Murphy BR. Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesis. Vaccine. 1994 Jun; 12(8):691-9. PMID: 8091846.
      View in: PubMed
    230. Murphy BR, Hall SL, Kulkarni AB, Crowe JE, Collins PL, Connors M, Karron RA, Chanock RM. An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines. Virus Res. 1994 Apr; 32(1):13-36. PMID: 8030364.
      View in: PubMed
    231. Crowe JE, Murphy BR, Chanock RM, Williamson RA, Barbas CF, Burton DR. Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice. Proc Natl Acad Sci U S A. 1994 Feb 15; 91(4):1386-90. PMID: 8108420; PMCID: PMC43163.
    232. Crowe J, Döbeli H, Gentz R, Hochuli E, Stüber D, Henco K. 6xHis-Ni-NTA chromatography as a superior technique in recombinant protein expression/purification. Methods Mol Biol. 1994; 31:371-87. PMID: 7921034.
      View in: PubMed
    233. Crowe JE, Collins PL, London WT, Chanock RM, Murphy BR. A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV. Vaccine. 1993 Nov; 11(14):1395-404. PMID: 8310760.
      View in: PubMed
    234. Chanock RM, Crowe JE, Murphy BR, Burton DR. Human monoclonal antibody Fab fragments cloned from combinatorial libraries: potential usefulness in prevention and/or treatment of major human viral diseases. Infect Agents Dis. 1993 Jun; 2(3):118-31. PMID: 8173784.
      View in: PubMed
    235. Engeler CE, Olson PN, Engeler CM, Carpenter BL, Crowe JE, Day DL, Hertz MI, Bolman RM. Shifting pneumothorax after heart-lung transplantation. Radiology. 1992 Dec; 185(3):715-7. PMID: 1438751.
      View in: PubMed
    236. Barbas CF, Crowe JE, Cababa D, Jones TM, Zebedee SL, Murphy BR, Chanock RM, Burton DR. Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity. Proc Natl Acad Sci U S A. 1992 Nov 1; 89(21):10164-8. PMID: 1279672; PMCID: PMC50298.
    237. Bulger K, Griffin M, Dervan P, Lennon J, Crowe J. Coeliac disease in association with inflammatory bowel disease. Postgrad Med J. 1988 Apr; 64(750):336. PMID: 3186585; PMCID: PMC2428489.
    238. Bulger K, Griffin M, O'Brien M, Crowe J. Lymphoma in the mesenteric lymph node cavitation syndrome. Gastroenterology. 1988 Feb; 94(2):553. PMID: 3335328.
      View in: PubMed
    239. Christensen E, Neuberger J, Crowe J, Portmann B, Williams R, Altman DG, Popper H, Doniach D, Ranek L, Tygstrup N. Azathioprine and prognosis in primary biliary cirrhosis. Gastroenterology. 1986 Feb; 90(2):508-9. PMID: 3510149.
      View in: PubMed
    240. Christensen E, Neuberger J, Crowe J, Altman DG, Popper H, Portmann B, Doniach D, Ranek L, Tygstrup N, Williams R. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. Gastroenterology. 1985 Nov; 89(5):1084-91. PMID: 3899841.
      View in: PubMed
    241. Sumner TE, Crowe JE, Klein A, McKone RC, Weaver RL. Intrapericardial teratoma in infancy. Pediatr Radiol. 1980 Sep; 10(1):51-3. PMID: 7422393.
      View in: PubMed
    242. Crowe J, Christensen E, Smith M, Cochrane M, Ranek L, Watkinson G, Doniach D, Popper H, Tygstrup N, Williams R. Azathioprine in primary biliary cirrhosis: a preliminary report of an international trial. Gastroenterology. 1980 May; 78(5 Pt 1):1005-10. PMID: 6991353.
      View in: PubMed
    243. Sumner TE, Crowe JE, Parker MD, White JP. Solitary spinal metastasis from Wilms' tumor. Pediatr Radiol. 1980 Apr; 9(3):175-6. PMID: 6248834.
      View in: PubMed
    244. Christensen E, Crowe J, Doniach D, Popper H, Ranek L, Rodés J, Tygstrup N, Williams R. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients. Gastroenterology. 1980 Feb; 78(2):236-46. PMID: 7350046.
      View in: PubMed
    245. Sumner TE, Phelps CR, Crowe JE, Poolos SP, Shaffner LD. Pulmonary blastoma in a child. AJR Am J Roentgenol. 1979 Jul; 133(1):147-8. PMID: 110053.
      View in: PubMed
    246. Brasch RC, Royal S, Ammann AJ, Crowe J. Pseudolymphoma in two immunodeficient children. AJR Am J Roentgenol. 1979 May; 132(5):844-7. PMID: 107763.
      View in: PubMed
    247. Sumner T, Friedland GW, Parker B, Thomas J, Crowe J, Resnick M. Preoperative diagnosis of unilateral multicystic kidney with hydropelvis. Urology. 1978 May; 11(5):519-22. PMID: 675913.
      View in: PubMed
    248. Crowe JE, Sumner TE. Combined esophageal and duodenal atresia without tracheoesophageal fustula: characteristic radiographic changes. AJR Am J Roentgenol. 1978 Jan; 130(1):167-8. PMID: 413406.
      View in: PubMed
    249. Swischuk LE, Crowe JE, Mewborne EJ. Large vein of Galen aneurysms in the neonate. A constellation of diagnostic chest and neck radiologic findings. Pediatr Radiol. 1977 Jul 25; 6(1):4-9. PMID: 142234.
      View in: PubMed
    250. Crowe JE, Swischuk LE. Acute bowing fractures of the forearm in children: a frequently missed injury. AJR Am J Roentgenol. 1977 Jun; 128(6):981-4. PMID: 414566.
      View in: PubMed
    251. Crowe JE. Removal of blunt esophageal foreign bodies: Foley catheter technique. N C Med J. 1976 Aug; 37(8):431-2. PMID: 1067479.
      View in: PubMed
    CROWE's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _